Gordon W Blair Selected Research

isosorbide-5-mononitrate (Ismo)

1/2022	Effects of Cilostazol and Isosorbide Mononitrate on Cerebral Hemodynamics in the LACI-1 Randomized Controlled Trial.
5/2019	Tolerability, safety and intermediary pharmacological effects of cilostazol and isosorbide mononitrate, alone and combined, in patients with lacunar ischaemic stroke: The LACunar Intervention-1 (LACI-1) trial, a randomised clinical trial.
1/2019	Effects of Isosorbide Mononitrate and/or Cilostazol on Hematological Markers, Platelet Function, and Hemodynamics in Patients With Lacunar Ischaemic Stroke: Safety Data From the Lacunar Intervention-1 (LACI-1) Trial.
1/2018	Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gordon W Blair Research Topics

Disease

5	Ischemic Stroke 01/2022 - 01/2019
4	Lacunar Stroke 01/2020 - 01/2018
3	Stroke (Strokes) 01/2020 - 01/2018
2	Cognitive Dysfunction 01/2020 - 01/2018
2	Cerebral Small Vessel Diseases 02/2019 - 01/2019
1	Disease Progression 03/2021
1	Hemorrhage 01/2020
1	Hemorrhagic Stroke 01/2020
1	Headache (Headaches) 01/2020

Drug/Important Bio-Agent (IBA)

5	Cilostazol (Pletal)FDA LinkGeneric 01/2022 - 01/2018
4	isosorbide-5-mononitrate (Ismo)FDA LinkGeneric 01/2022 - 01/2018
1	ORALIT (ORS)IBA 01/2020
1	Clopidogrel (Plavix)FDA Link 01/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2020
1	Retinaldehyde (Retinal)IBA 01/2020
1	Phosphodiesterase 3 InhibitorsIBA 01/2020
1	ferric oxide (iron oxide)IBA 02/2019
1	ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA 02/2019

Therapy/Procedure

2	Secondary Prevention 01/2020 - 05/2019
1	Therapeutics 03/2021